Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Invivac 2006/2007 seasonal influenza vaccine immunogenicity study
2006-001301-28Phase 3Completed
- Sponsor
- Solvay Pharmaceuticals
- Start
- Apr 2006
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of virosomal influenza vaccine in influenza (2 arms), sponsored by Solvay Pharmaceuticals. Primary endpoints: Serological parameters derived from observed hemagglutination inhibition titers and Immunogenicity. Started Apr 2006; status: completed.
02
Drugs
virosomal influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2006-001301-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001301-28.